⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GKOS News
Glaukos Corporation
Form 8-K
sec.gov
GKOS
Glaukos Announces Fourth Quarter and Full Year 2025 Financial Results
businesswire.com
GKOS
Glaukos Announces Fourth Quarter and Full Year 2025 Financial Results
businesswire.com
GKOS
iVeena Delivery Systems Announces First Patient Dosed in Phase 1 Study of IVMED-85 in Healthy Adult Volunteers
businesswire.com
GKOS
iVeena Delivery Systems Announces Strategic Leadership Promotions to Accelerate Growth and Scientific Innovation
businesswire.com
GKOS
Ophthalmic Equipment Market - Global Forecast to 2030 with Case Studies from Zeiss, Indian Government, and Heidelberg Engineering
globenewswire.com
ALC
JNJ
GKOS
Glaukos Announces US FDA Approval of NDA Supplement Allowing for Re-Administration of iDose ® TR
businesswire.com
GKOS
Glaukos to Release Fourth Quarter and Full Year 2025 Financial Results after Market Close on February 17
businesswire.com
GKOS
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue Guidance
businesswire.com
GKOS
Glaukos Announces Participation in J.P. Morgan Healthcare Conference
businesswire.com
GKOS